Latest Breaking News On - Global economic burden - Page 1 : comparemela.com

EpiEndo Pharmaceuticals: EpiEndo reports Phase 2A results for lead asset, EP395, in COPD

EpiEndo Pharmaceuticals: EpiEndo reports Phase 2A results for lead asset, EP395, in COPD
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomSchleswig holsteinHenrik watzDennis riedlDave singhMaria bechGinny norrisPulmonary research instituteEpiendo pharmaceuticalsUniversity of manchesterWorld economic forumEndo pharmaceuticalsChronic obstructive pulmonary diseasePrincipal investigatorsProfessor dave singhRespiratory pharmacology

EpiEndo reports Phase 2A results for lead asset, EP395, in COPD

REYKJAVIK, Iceland, April 10, 2024 EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), a clinical-stage biopharmaceutical company developing a new class of oral, barrier-enhancing, anti-inflammatory therapeutics addressing chronic airway diseases, announces the successful completion of its Phase 2A clinical trial for EP395 in patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD).

United kingdomSchleswig holsteinGinny norrisMaria bechDave singhHenrik watzEpiendo pharmaceuticalsUniversity of manchesterWorld economic forumPulmonary research instituteChronic obstructive pulmonary diseasePrincipal investigatorsProfessor dave singhRespiratory pharmacologyMedical directorMedicines evaluation unit

Sticking together makes bacteria nearly invincible

New treatments are trying to drive them apart

City ofUnited kingdomUnited statesSteven goodmanTiago costaStefan ryserBrendan gilmoreDave richardsBritain national biofilm innovation centreLauren bakaletz at ohio state universityUniversity of southern californiaMontana state universityUniversity of copenhagenCommunications biologyImperial college londonQueen university belfast

Speaking Up for COPD: A global call for policy action

Transformation in COPD care is underway as Speak Up for COPD unites policymakers, healthcare professionals, patients, caregivers, NGOs, and pharmaceutical industry to help make COPD a public health priority.

United kingdomUnited statesGitta vanpeborghInternational coalition of respiratory nursesFramework convention on tobaccoLancet commissionUnited nations sustainable development goals sdgsWorld economic forumGlobal initiative for chronic obstructive lung diseaseGlobal allergy airways patient platformInternational pharmaceutical federationWorld health organizationInternational journal of chronic obstructive pulmonary diseaseHuman health effects of air pollutionLancet planetary healthLancet glob health

Making COPD a public health priority starts here: understanding the condition

A recent poll of 14,890 members of the public in 14 countries underscores the need for greater awareness and prioritization of evidence-based COPD care.

United statesMohamed azmi ahmad hassaliAhmad salmanHyder aliSameen abbasShahid shahSohail ayaz muhammadExpert review of pharmacoeconomics outcomes researchInternational respiratory coalitionWorld economic forumCommunicable diseases ncds initiativeInternational coalition of respiratory nursesLancet commissionCanadian institute for health informationInternational federation of ageingInternational pharmaceutical federation